ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis

Kaori Ishikawa1, Keizo Takenaga, Miho Akimoto

  • 1Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8572, Japan.

Science (New York, N.Y.)
|April 5, 2008
PubMed

Insights

Mitochondrial DNA (mtDNA) mutations in cancer cells can enhance their ability to metastasize. Replacing mtDNA between cell lines showed that specific mutations in the ND6 gene increased tumor cell metastatic potential by affecting respiration and reactive oxygen species (ROS) production.

Area of Science:

  • Cancer Biology
  • Mitochondrial Genetics
  • Tumor Metastasis

Background:

  • Mitochondrial DNA (mtDNA) mutations are frequent in human tumors.
  • The functional impact of mtDNA mutations on tumor cell behavior, particularly metastasis, remains largely unclear.

Purpose of the Study:

  • To investigate whether mtDNA mutations influence the metastatic potential of tumor cells.
  • To determine if specific mtDNA mutations can confer or suppress metastatic ability.

Main Methods:

  • Utilized cytoplasmic hybrid (cybrid) technology to exchange mtDNA between poorly and highly metastatic mouse tumor cell lines.
  • Assessed metastasis in vivo in mice following mtDNA transfer.
  • Analyzed specific mtDNA mutations (G13997A and 13885insC in ND6 gene) and their effect on respiratory complex I activity and reactive oxygen species (ROS) production.

Main Results:

  • Tumor cells acquired the metastatic potential of the transferred mtDNA.
  • mtDNA conferring high metastatic potential harbored G13997A and 13885insC mutations in the ND6 gene.
  • These mutations led to respiratory complex I deficiency and increased ROS production, which was linked to enhanced metastasis.

Conclusions:

  • mtDNA mutations can significantly contribute to tumor progression by enhancing metastatic potential.
  • Specific mtDNA mutations affecting cellular respiration and ROS levels are key drivers of cancer metastasis.
  • Targeting ROS may represent a therapeutic strategy to inhibit mtDNA-driven tumor cell metastasis.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations01:39

Mutations

Overview
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...